Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10216)
All Articles published online
|
Publishing Process of This Article
|
Jul 6, 2019 (publication date) through Dec 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Zhang MY, Niu JQ, Wen XY, Jin QL. Liver failure associated with benzbromarone: A case report and review of the literature. World J Clin Cases 2019; 7(13): 1717-1725 [PMID: 31367632 DOI: 10.12998/wjcc.v7.i13.1717] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Zhang MY, Niu JQ, Wen XY, Jin QL. Liver failure associated with benzbromarone: A case report and review of the literature. World J Clin Cases 2019; 7(13): 1717-1725 [PMID: 31367632 DOI: 10.12998/wjcc.v7.i13.1717] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v7/i13/1717.htm |
| Number | Citing Articles |
| 1 |
Yun-Hong Cheon, Jung Soo Song. What is the Best Choice for Urate-lowering Therapy for Korean?. Journal of Rheumatic Diseases 2020; 27(2): 78 doi: 10.4078/jrd.2020.27.2.78
|
| 2 |
Yue Yu, Haodong Zhong, Qianyi Niu, Manman Zhao, Bo Li, Xiaobing Zhou.
Establishment and validation of an
in vitro
liver model based extracellular matrix for hepatotoxicity prediction
. Human & Experimental Toxicology 2025; 44 doi: 10.1177/09603271251350797
|
| 3 |
Wenyan Sun, Lingling Cui, Robert Terkeltaub, Ying Chen, Xinde Li, Xiaoyu Cheng, Tian Liu, Nicola Dalbeth, Changgui Li. Risk of Hepatotoxicity in Patients With Gout Treated With Febuxostat or Benzbromarone: A Propensity Score–Matched Cohort Study. Arthritis Care & Research 2025; 77(9): 1149 doi: 10.1002/acr.25547
|
| 4 |
Sree Hari Reddy Gadekallu. Overestimating the risk of febuxostat's hepatotoxicity? comment on the article by Sun et al. Arthritis Care & Research 2025; doi: 10.1002/acr.25663
|
| 5 |
Chunyong He, Yuchang Mao, Hong Wan. In-depth understanding of the structure-based reactive metabolite formation of organic functional groups. Drug Metabolism Reviews 2025; 57(2): 147 doi: 10.1080/03602532.2025.2472076
|
| 6 |
M.V. Tkachenko, M.Yu. Babanina, H.V. Volchenko, Ye.M. Kitura, O.A. Kyryan . MODERN VIEW ON ANTI-INFLAMMATORY AND URAT-LOWERING THERAPY FOR GOUT. Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії 2023; 23(3): 217 doi: 10.31718/2077-1096.23.3.217
|
| 7 |
Xiaoyu Shen, Yejian Mo, Jian Ren, Kexin Liu, Shili Sun, Chunlin Deng. Inhibition of xanthine oxidase by copper-gallate coordination polymers and its mechanistic study. Journal of Molecular Structure 2025; 1346: 142912 doi: 10.1016/j.molstruc.2025.142912
|
| 8 |
Promsuk Jutabha, Vijay Kumar, Naohiko Anzai, Peter Rice, Janet Lightner, Hitoshi Endou, Michael Wempe. Benzbromarone Analog SAR: Potent hURAT1 (SLC22A12) Inhibitors and Drug Transporter Interaction Studies. Drug Design, Development and Therapy 2025; : 1377 doi: 10.2147/DDDT.S474398
|
| 9 |
Connor J. Hughes, Christopher Alderman, Arthur R. Wolin, Kaiah M. Fields, Rui Zhao, Heide L. Ford. All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(3): 189098 doi: 10.1016/j.bbcan.2024.189098
|
| 10 |
Yun Liu, Qian Chen, Hui Sun, Cuiyuan Cai, Kotomi Kawamura, Rieko Kokan, Maiko Nomoto. A Single- and Multiple-Dose Study to Characterize the Pharmacokinetics and Safety of Dotinurad in Healthy Chinese Adults. Clinical Drug Investigation 2025; 45(12): 957 doi: 10.1007/s40261-025-01496-x
|
| 11 |
A. A. Garanin, N. L. Novichkova, N. L. Novichkova. Prospects of anti-inflammatory and urate-lowering therapy of gout: A vector from the past to the future. Rheumatology Science and Practice 2022; 60(2): 205 doi: 10.47360/1995-4484-2022-205-213
|
| 12 |
Wenwen Zhang, Yifang Cui, Zihan Liu, Shaoping Wang, Ailin Yang, Xiulian Li, Jiayu Zhang. Astragalus membranaceus ultrafine powder alleviates hyperuricemia by regulating the gut microbiome and reversing bile acid and adrenal hormone biosynthesis dysregulation. Arabian Journal of Chemistry 2022; 15(9): 103970 doi: 10.1016/j.arabjc.2022.103970
|
| 13 |
Jing Liu, Ge Liu, Teng Chu, Yue Wu, Lele Zixin Yang, Weirong Fang. The Progress of Immune Cells-induced Inflammatory Response in Gout. Current Pharmaceutical Design 2025; 31(31): 2465 doi: 10.2174/0113816128369016250306050522
|
| 14 |
Mizuki Yamane, Fumihiko Igarashi, Tsuyoshi Yamauchi, Toshito Nakagawa. Main contribution of UGT1A1 and CYP2C9 in the metabolism of UR-1102, a novel agent for the treatment of gout. Xenobiotica 2021; 51(1): 61 doi: 10.1080/00498254.2020.1812012
|
| 15 |
Linjian Zhang, Kaijun Su, Haoshu Zhang, Guowei Zhang, Jian Zhou, Jiaqi Liang, Xiang Li, Xiaojin Zhang. Benzoheterocyclic analogues of dotinurad as orally efficacious human urate transporter 1 inhibitors: Design, synthesis, structure-activity relationships, and pharmacokinetic studies. European Journal of Medicinal Chemistry 2026; 303: 118459 doi: 10.1016/j.ejmech.2025.118459
|
| 16 |
Yuanfan Wu, Xia Sun, Yuhan Jia, Tianshu Gao, Jin Xu, Youqiao Qian, Naiqi Pei, Lilin Wang, Qiaohong Zheng, Honglei Li, Zhen Chen, Yijiao Liu, Yang Ma, Hui Chen, Yuanyuan Ye, Jiaxin Zhao, Yi Zhou, Xiaoqing Chen, Baosheng Huang, Yefeng Liu, Yin Zhu, Ning Xue, Juan Zhang, Guangfeng Ji, Xing Wang. Therapeutic effect and mechanism of gigantol on hyperuricemia. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1474808
|
| 17 |
Yuan Hong, Xichuang Chen, Zhiping Li, Xiaoyan Zhang, Cong Zhou, Yan Wang, Guangfei Wang, Wei Wu, Danli Zhou, Hai feng Li. A lifetime economic research of universal HLA-B*58:01 genotyping or febuxostat initiation therapy in Chinese gout patients with mild to moderate chronic kidney disease. Pharmacogenetics and Genomics 2023; 33(2): 24 doi: 10.1097/FPC.0000000000000488
|
| 18 |
Zhixi Dai, Hongming Chen, Xiaodan Lu, Haojie Cai, Lei Zhang, Jing Li. Development of a fluorescence-based assay for screening of urate transporter 1 inhibitors (II): Optimization of fluorescent substrates and structure-activity relationships analysis. Journal of Pharmaceutical and Biomedical Analysis 2025; 262: 116900 doi: 10.1016/j.jpba.2025.116900
|
| 19 |
Alessandro Maloberti, Valentina Colombo, Francesca Daus, Lorenzo De Censi, Maurizio Giuseppe Abrignani, Pier Luigi Temporelli, Giulio Binaghi, Furio Colivicchi, Massimo Grimaldi, Domenico Gabrielli, Claudio Borghi, Fabrizio Oliva. Two still unanswered questions about uric acid and cardiovascular prevention: Is a specific uric acid cut-off needed? Is hypouricemic treatment able to reduce cardiovascular risk?. Nutrition, Metabolism and Cardiovascular Diseases 2025; 35(3): 103792 doi: 10.1016/j.numecd.2024.103792
|
| 20 |
Kaiji Li, Jinchao Wang, Yalong Gao, Xin Chen, Ruilong Peng, Lei Li, Cong Wang, Tuo Li, Shu Zhang, Guili Yang, Jianning Zhang. Benzbromarone improves blood hypercoagulability after TBI by reducing phosphatidylserine externalization through inhibition of TMEM16F expression. Life Sciences 2025; : 123501 doi: 10.1016/j.lfs.2025.123501
|
| 21 |
Xiaowei Luo, Lipeng Zhou, Shukai Wang, Jing Yuan, Zihao Chang, Qian Hu, Yinxin Chen, Yuqi Liu, Ya Huang, Baojin Wang, Ye Gao, Zhaohui Wang, Yitong Cui, Yue Liu, Lanzhen Zhang. The Therapeutic Effect and the Potential Mechanism of Flavonoids and Phenolics of Moringa oleifera Lam. Leaves against Hyperuricemia Mice. Molecules 2022; 27(23): 8237 doi: 10.3390/molecules27238237
|
| 22 |
Tomotaka Ishii, Keijiro Hoshino, Masayuki Honda, Yoichiro Yamana, Reina Sasaki-Tanaka, Mariko Kumagawa, Shini Kanezawa, Taku Mizutani, Naoki Matsumoto, Ryota Masuzaki, Kazushige Nirei, Hiroaki Yamagami, Mitsuhiko Moriyama, Tatsuo Kanda. A Case of Recent Liver Injury Induced by Benzbromarone. Reports 2022; 5(1): 8 doi: 10.3390/reports5010008
|
| 23 |
Zihan Hou, Aijinxiu Ma, Jiale Mao, Danni Song, Xu Zhao. Overview of the pharmacokinetics and pharmacodynamics of URAT1 inhibitors for the treatment of hyperuricemia and gout. Expert Opinion on Drug Metabolism & Toxicology 2023; 19(12): 895 doi: 10.1080/17425255.2023.2287477
|
| 24 |
N. A. Konyshko, T. E. Morozova, V. V. Tsurko, G. S. Konyshko. Hyperuricemia, gout and digestive system pathology: common links of pathogenesis. Experimental and Clinical Gastroenterology 2024; (11): 130 doi: 10.31146/1682-8658-ecg-219-11-130-137
|
| 25 |
Jiaxin Zhang, Liang Hong, Wenfei Xu, Xin Zhang, Huina Fu, Xinan Song, Jing Zhao, Gayathiri Ekambaram. Gout management: Patent analytics and computational drug design explores URAT1 inhibitors landscape. PLOS One 2025; 20(8): e0328559 doi: 10.1371/journal.pone.0328559
|
| 26 |
Yang Suo, Justin G. Fedor, Han Zhang, Kalina Tsolova, Xiaoyu Shi, Kedar Sharma, Shweta Kumari, Mario Borgnia, Peng Zhan, Wonpil Im, Seok-Yong Lee. Molecular basis of the urate transporter URAT1 inhibition by gout drugs. Nature Communications 2025; 16(1) doi: 10.1038/s41467-025-60480-3
|